Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies
Yasser Hussein Eissa Mohammed(University of Sharjah), Amgad M. Rabie(Alkermes (Ireland)), Elshiekh B. Khidir(Umm al-Qura University), Hind A. Alzahrani(Al Baha University), Basit Jabbar(University of the Punjab), Mohammed A. Shanawaz(Al Baha University), Saad Alghamdi(Umm al-Qura University), Israa M. Shamkh(Cairo University), Saba Beigh(Al Baha University), Nada Alsakhen(Hashemite University), Nahed S. Alharthi(Prince Sattam Bin Abdulaziz University), Taqwa Hafiz Elamin Karamalla(Helwan University), Hayaa M. Alhuthali(Taif University)
Cited by 22
Related Papers
Innovative nano-carriers in anticancer drug delivery-a comprehensive review
|Bioorganic Chemistry|2019|166
Vision for medicine: Staphylococcus aureus biofilm war and unlocking key's for anti-biofilm drug development
|Microbial Pathogenesis|2018|97
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
|Journal of Hepatology|2023|94